Todd Durham

Todd Durham Email and Phone Number

Sr. Vice President, Clinical and Outcomes Research at Foundation Fighting Blindness @ Foundation Fighting Blindness
columbia, maryland, united states
Todd Durham's Location
Raleigh-Durham-Chapel Hill Area, United States
About Todd Durham

An accomplished, solutions-focused International Health & Clinical Research Leader, I have two decades of experience directing clinical and health research to expand and improve the treatment of patients worldwide.With a unique background in biostatistical, clinical, and outcomes research, drug development, and business leadership, my primary focus has centered on delivering insights and opportunities to optimize value for drug developers, investors, stakeholders, and healthcare-based entities, including foundations and nonprofits. A skilled data interpreter, I have a record of designing, building and strengthening products and programs to deliver positive ROI for investments in the pharma arena.Through the years, I have built clinical research programs, secured and overseen research grants, and led work that resulted in numerous FDA approvals. My experience crosses over multiple domains, including rare diseases, nonprofit, and foundation work, directing nonclinical Phase 1-4 development and post-marketing studies across various therapeutic areas. I have contributed to a number of peer-reviewed articles (both clinical and statistical) and am the co-author of two books, Introduction to Statistics in Pharmaceutical Clinical Trials (Pharmaceutical Press, 2008) and Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development and Postmarketing Surveillance (Wiley, 2008). I currently serve as SVP of Clinical & Outcomes Research and Principal Investigator for the Foundation Fighting Blindness, responsible for a 25,000-participant registry and genetic testing program of individuals affected by inherited retinal disease. In addition to the SVP role, I am currently serving a four-year term as a special governmental employee for the FDA, representing the consumer perspective on the Dermatologic and Ophthalmic Drugs Advisory Committee. I am also an adjunct associate professor for Gillings School of Global Public Health at the University of North Carolina - Chapel Hil, teaching graduate courses in operations research.I completed my doctoral fellowship with Bristol Myers Squibb and have been previously employed by Axio Research, Inspire Pharmaceuticals, Quintiles, IQVIA, and Novan.My therapeutic areas of expertise include cystic fibrosis, dry eye disease, glaucoma, cardiovascular, alcohol dependence, pain, hypercholesterolemia, acne vulgaris, psoriasis, atopic dermatitis, and inherited retinal disease.Connect with me via LinkedIn messaging.

Todd Durham's Current Company Details
Foundation Fighting Blindness

Foundation Fighting Blindness

View
Sr. Vice President, Clinical and Outcomes Research at Foundation Fighting Blindness
columbia, maryland, united states
Employees:
120
Todd Durham Work Experience Details
  • Foundation Fighting Blindness
    Sr. Vice President, Clinical And Outcomes Research
    Foundation Fighting Blindness Jan 2019 - Present
    Raleigh-Durham, North Carolina Area
    Principal Investigator, responsible for a 25,000-participant registry and genetic testing program of individuals affected with inherited retinal disease. Building collaborative models and clinical consortiums, bringing together researchers and leaders from academia and industry interested in retinal disease. • Provide senior leadership and strategic guidance to clinical research activities conducted through the Foundation’s Consortium of 40+ inherited retinal disease specialists• Guided… Show more Principal Investigator, responsible for a 25,000-participant registry and genetic testing program of individuals affected with inherited retinal disease. Building collaborative models and clinical consortiums, bringing together researchers and leaders from academia and industry interested in retinal disease. • Provide senior leadership and strategic guidance to clinical research activities conducted through the Foundation’s Consortium of 40+ inherited retinal disease specialists• Guided significant investment in, and increased impact of the sponsored genetic testing program by securing a successful research partnership with the National Eye Institute, developing a strategic plan for funding the program, diversifying funding sources, and doubling the number of people now able to access genetic testing at no cost • Overseeing a $30M clinical research budget while developing and managing the performance of a 4-member internal team, and a 6-member outsourced team of researchers• Pivotal role in securing $3+M in research funding partnering with nonprofits, large Fortune 100 pharma, and biotech companies • Organize and conduct disease-specific scientific workshops that include the perspectives of affected individuals, researchers, clinicians, and regulatory representatives Show less
  • Novan, Inc.
    Head Of Biometrics
    Novan, Inc. Jan 2018 - Dec 2018
    Raleigh-Durham, North Carolina Area
    Owned contract research agreements and partnerships between $500K and $1M, each, providing expert biostatistical input on study design and analysis for Phase 1-3 clinical studies in dermatology. Contributed to portfolio management, presenting clinical trial results, assessing portfolio strength, and recommending which assets to pursue to deliver the most success for the patient and the company. • Built state-of-the-art statistical methods for portfolio management and opportunity assessment… Show more Owned contract research agreements and partnerships between $500K and $1M, each, providing expert biostatistical input on study design and analysis for Phase 1-3 clinical studies in dermatology. Contributed to portfolio management, presenting clinical trial results, assessing portfolio strength, and recommending which assets to pursue to deliver the most success for the patient and the company. • Built state-of-the-art statistical methods for portfolio management and opportunity assessment for the acne market, providing swift access to insights on ROI for proposed acquisitions and development • Supported scientific publications – authored, edited, and published peer-reviewed articles Show less
  • Iqvia
    Director Biostatistics, Real-World And Late Phase Research
    Iqvia Feb 2017 - Dec 2017
    Raleigh-Durham, North Carolina Area
    Drove business development while serving as lead statistician on large, complex real-world studies focused on cardiovascular (CV) indications – securing and managing partnerships with leading pharmaceutical companies to support their product innovation. • Responsible for a $1M project budget, part of a larger strategic partnership with contracts up to $10M• Strengthened a 4-member biostatistics team, accelerating on-time delivery and quality client studies
  • Durham Statistical Consulting Llc
    President And Statistical Consultant
    Durham Statistical Consulting Llc Jun 2011 - Jan 2017
    Durham, Nc
    Built a consulting firm and strong client base serving small biotech companies, providing due diligence on product ideas, and advising on product acquisitions and mergers. Designed studies, analyzed data, and prepared manuscripts including glaucoma, dry eye, cystic fibrosis, and manufacturing quality. • Used Phase 3 data and Monte Carlo simulation to estimate the probability of technical success and select optimal multiple-testing strategies
  • Bristol-Myers Squibb
    Doctoral Fellow, Worldwide Health Economics And Outcomes Research
    Bristol-Myers Squibb Aug 2014 - Jul 2016
    Princeton, Nj
    Assisted with developing protocols, manuscripts, and posters for observational studies using administrative claims data and electronic health records; led literature reviews to identify priorities for real-world research opportunities. This role was connected to the doctoral program at UNC-Chapel Hill.
  • Axio Research
    Director, Eastern Operations
    Axio Research May 2011 - Dec 2013
    Rtp, Nc
    Identified business opportunities and partnerships, developed and secured numerous project proposals, provided statistics consulting and analysis services to drugs, devices, and biologics developers, and drove new business to the organization. Held role while pursuing PhD.
  • Inspire Pharmaceuticals
    Senior Director, Biostatistics And Data Management
    Inspire Pharmaceuticals Jun 2004 - Apr 2011
    Championed transformation in role with processes, performance, and adoption of new statistical approaches to estimate the probability of success as a portfolio management tool for product innovation. • Managed projects of up to $1M and a 7-member staff of data, statisticians, programmer personnel• Earned corporate award for Best Science, leveraging statistical methods to optimize portfolio

Todd Durham Education Details

Frequently Asked Questions about Todd Durham

What company does Todd Durham work for?

Todd Durham works for Foundation Fighting Blindness

What is Todd Durham's role at the current company?

Todd Durham's current role is Sr. Vice President, Clinical and Outcomes Research at Foundation Fighting Blindness.

What schools did Todd Durham attend?

Todd Durham attended University Of North Carolina At Chapel Hill, University Of North Carolina At Chapel Hill, University Of North Carolina At Chapel Hill.

Who are Todd Durham's colleagues?

Todd Durham's colleagues are Bonnie Little, Juliana Gaona, Lesley Ireland, Angela Bowman, Reid Fellner, Cassandra Fridovich, Lesley Ireland.

Not the Todd Durham you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.